Introduction
Materials and methods
Study design and participants
Dietary intake assessment
Construction of Med-DQI
Scoring | 0 | 1 | 2 |
---|---|---|---|
Saturated fatty acids (% energy) | < 10 | 10–13 | > 13 |
Cholesterol (milligram) | < 300 | 300–400 | > 400 |
Meats (gram) | < 25 | 25–125 | > 125 |
Olive oil (milliliter) | > 15 | 15–5 | < 5 |
Fish (gram) | > 60 | 60–30 | < 30 |
Cereals (gram) | > 300 | 300–100 | < 100 |
Vegetables + fruits (gram) | > 700 | 700–400 | < 400 |
Assessment of other variables
Statistical analyses
Results
Breast cancer | Quartiles of Mediterranean Dietary Quality Index | |||||||
---|---|---|---|---|---|---|---|---|
Yes (n = 150) | No (n = 150) | P* | Q1 (n = 103) MedDQI score range: 3–5 | Q2 (n = 91) | Q3 (n = 49) | Q4 (n = 57) MedDQI score range:8–11 | P* | |
Age (y) | 46.6 ± 10.7 | 46.6 ± 10.7 |
< 0.001
| 47.0 ± 10.5 | 47.1 ± 10.0 | 44.5 ± 10.5 | 46.6 ± 12.3 | 0.4 |
BMI (kg/m2) | 28.1 ± 4.6 | 28.2 ± 5.2 | 0.8 | 28.70 ± 5.32 | 28.73 ± 4.66 | 27.84 ± 4.25 | 26.65 ± 4.97 |
0.01
|
Physical activity (Met/min/week) | 475.8 ± 1043.2 | 590.0 ± 843.8 | 0.2 | 644.4 ± 970.2 | 406.8 ± 708 | 388.8 ± 561 | 655.8 ± 1389.6 | 0.8 |
Family history of breast cancer yes, (%) | 30 (20) | 39 (26) | 0.2 | 21 (20.4) | 20 (22) | 12 (24.5) | 16 (28) | 0.8 |
University graduated n, (%) | 21 (14) | 28 (18.7) | 0.6 | 19 (18.5) | 13 (14.3) | 8 (16.3) | 9 (15.9) | 0.3 |
Urban-resided n, (%) | 140 (93.3) | 139 (92.7) | 0.8 | 99 (96.1) | 85 (93.4) | 46 (93.9) | 49 (86) | 0.1 |
Married, n (%) | 129 (86) | 136 (90.7) | 0.2 | 86 (83.5) | 83 (91.2) | 46 (93.9) | 50 (87.7) | 0.5 |
Menopause status yes, n (%) | 62 (41.3) | 54 (36) | 0.3 | 41 (39.8) | 37 (40.7) | 15 (30.6) | 23 (40.4) | 0.6 |
Age at first menarche (year) | 14.4 ± 1.7 | 13.4 ± 1.6 | 0.2 | 14.7 (1.7) | 13.6 (1.2) | 13.2 (1.5) | 13.6 (1.7) | 0.2 |
Number of child, n | 2.6 ± 2.1 | 2.4 ± 2.1 | 0.3 | 2.5 (1.9) | 2.5 (2.4) | 2.3 (1.6) | 2.6 (2.3) | 0.9 |
Length of breastfeeding (year) | 4.2 ± 3.5 | 3.5 ± 2.7 |
0.059
| 4.07 (3.3) | 3.8 (2.8) | 3.3 (3.1) | 4.2 (3.2) | 0.8 |
History of HRT, n (%) | 12 (8) | 8 (5.3) | 0.3 | 6 (5.8) | 2 (2.2) | 6 (12.2) | 2 (10.5) | 0.07 |
Smoking, never smoked, n (%) | 147 (98) | 144 (96) | 0.3 | 101 (98.1) | 87 (95.6) | 47 (95.9) | 56 (98.2) | 0.7 |
Alcohol, never used, n (%) | 149 (99) | 148 (98) | 0.5 | 102 (99) | 90 (98.9) | 48 (98) | 57 (100) | 0.5 |
Dietary supplement use, yes, n (%) | 80 (53.3) | 84 (56) | 0.09 | 61 (59.2) | 49 (53.8) | 24 (49) | 30 (52.6) | 0.6 |
Medication use §,yes, n (%) | 64 (42) | 62 (41) | 0.8 | 45 (43.7) | 37 (40.7) | 18 (36.7) | 26 (45.6) | 0.3 |
Comorbidities †, n (%) | 38 (25) | 31 (20) | 0.3 | 46 (44.7) | 42 (46.2) | 26 (53.1) | 29 (50.9) | 0.3 |
Breast cancer | Quartiles of Mediterranean Dietary Quality Index | |||||||
---|---|---|---|---|---|---|---|---|
Yes (n = 150) | No (n = 150) | P* | Q1 (n = 103) MedDQI score range: 3–5 | Q2 (n = 91) | Q3 (n = 49) | Q4 (n = 57) MedDQI score range: 8–11 | P* | |
Saturated fatty acids (% energy) | 9.1 ± 4 | 8.1 ± 3 |
0.02
| 6.9 ± 1.9 | 7.7 ± 2.3 | 8.9 ± 2.7 | 12.7 ± 4.8 |
< 0.001
|
Cholesterol (mg/d) | 255 ± 117 | 229 ± 126 | 0.06 | 194 ± 63 | 208 ± 74 | 269 ± 112 | 359 ± 179 |
< 0.001
|
Meats (gr/d) | 51.9 ± 41.9 | 46.6 ± 31.5 | 0.26 | 37.3 ± 22.2 | 44.5 ± 30.4 | 57.3 ± 47.4 | 71.6 ± 64.2 |
< 0.001
|
Olive oil (ml/d) | 1.9 ± 3.2 | 1.8 ± 3 | 0.82 | 3 ± 3.9 | 1.6 ± 2.7 | 0.8 ± 1.3 | 1 ± 2.4 |
< 0.001
|
Fish (gr/d) | 8.9 ± 11.7 | 7.8 ± 9 | 0.39 | 9.4 ± 13.1 | 7.5 ± 8.4 | 6.6 ± 8 | 9.2 ± 9.7 | 0.63 |
Cereals (gr/d) | 343 ± 288 | 495 ± 2390 | 0.44 | 633 ± 2875 | 299 ± 314 | 314 ± 225 | 314 ± 252 | 0.23 |
Vegetables + fruits (gr/d) | 999 ± 413 | 974 ± 343 | 0.57 | 1,098,326 | 958 ± 331 | 929 ± 433 | 881 ± 447 |
< 0.001
|
Energy intake (kcal/d) | 2914.1 ± 1159.0 | 2660.3 ± 799.6 |
0.02
| 3173.0 ± 1945.7 | 2888.0 ± 921.3 | 2980.4 ± 1040.9 | 2986.1 ± 995.7 | 0.06 |
OR (95% CI) | |||||
---|---|---|---|---|---|
Q1 MedDQI score range: 3–5 | Q2 | Q3 | Q4 MedDQI score range: 8–11 | P for trend | |
Total | |||||
No. of cases/controls | 52/51 | 37/54 | 22/27 | 39/18 | |
Crude | 1 | 1.48 (0.84–2.63) | 1.25 (0.63–2.47) | 0.47 (0.23–0.92) |
0.012
|
Model 1 | 1 | 1.49 (0.84–2.65) | 1.25 (0.63–2.5) | 0.47 (0.24–0.93) |
0.012
|
Model 2 | 1 | 1.45 (0.79–2.65) | 1.19 (0.58–2.45) | 0.45 (0.21–0.94) |
0.022
|
Model 3 | 1 | 1.45 (0.79–2.65) | 1.45 (0.79–2.65) | 0.45 (0.21–0.94) |
0.02
|
Premenopause | |||||
No. of cases/controls | 32/30 | 21/33 | 14/20 | 21/13 | |
Crude | 1 | 1.67 (0.8–3.51) | 1.52 (0.65–3.54) | 0.66 (0.28–1.54) | 0.15 |
Model 1 | 1 | 1.69 (0.8–3.56) | 1.54 (0.66–3.62) | 0.67 (0.28–1.59) | 0.16 |
Model 2 | 1 | 2.07 (0.94–4.58) | 1.57 (0.63–3.91) | 0.72 (0.28–1.8) | 0.11 |
Model 3 | 1 | 2.06 (0.93–4.55) | 1.57 (0.63–3.93) | 0.73 (0.28–1.54) | 0.12 |
Postmenopause | |||||
No. of cases/controls | 20/21 | 16/21 | 8/7 | 18/5 | |
Crude | 1 | 1.69 (0.51–3.56) | 0.83 (0.25–2.72) | 0.26 (0.08–0.84) | 0.07 |
Model 1 | 1 | 1.33 (0.53–3.34) | 0.9 (0.27–2.99) | 0.24 (0.07–0.8) |
0.055
|
Model 2 | 1 | 1.22 (0.44–3.39) | 1.05 (0.27–4.04) | 0.23 (0.05–0.91) | 0.1 |
Model 3 | 1 | 1.23 (0.44–3.46) | 0.9 (0.25–3.88) | 0.18 (0.04–0.77) | 0.06 |